Pharmaceutical Outsourcing Company Focus: A Russell Publishing Publication

COMPANY DESCRIPTION

Patheon is a $700 million, publicly traded, globally integrated provider of pharmaceutical development and manufacturing services. We work with twenty of the top thirty Big Pharma firms, nine of the top twenty specialty pharmaceutical companies, and ten of the top twenty biotechs.

COMPANY BACKGROUND

Our Team

Patheon’s development team is composed of more than 550 scientists and support staff, including 100 PhDs, producing over 300 development projects every single year, utilizing more than 40 dosage forms. Our executive team is made up of proven innovators with an average industry experience of 22 years, and our scientific leadership has an average of more than 20 years experience.

Our Network

Patheon operates a global network of ten manufacturing & packaging facilities, seven development centers, and numerous sales offices throughout North America, Europe, and Asia. Our development centers are in the United States, Canada, and Europe, and they leverage over 250,000 combined square feet of development space. Our manufacturing & packaging centers have over three million square feet of manufacturing space, annually producing more than 400 million packaged units and delivering to over 120 countries worldwide.

SERVICES & CAPABILITIES

Patheon’s services range from preclinical development through commercial manufacturing of a full array of dosage forms, including parenteral, solid, semi-solid and liquid forms. Patheon uses many innovative technologies, such as single-use disposables, Liquid-Filled Hard Capsules, and a variety of modified release technologies.
Our comprehensive range of fully integrated Pharmaceutical Development Services includes pre-formulation, formulation, analytical development, clinical manufacturing, scale-up and commercialization. Patheon can take customers direct to clinic with global clinical packaging and distribution services and Patheon’s Quick to Clinic™ programs can accelerate early phase development project to clinical trials while minimizing the consumption of valuable API.
Twenty-five of today’s Top 200 Prescription Drugs are manufactured by Patheon
Our Pharmaceutical Development Services have developed seven of today’s Top 200 Prescription Drugs
Ten of R&D Directions Magazine’s “100 Great Investigational Drugs” are in the process of being developed by Patheon today